Cargando…

Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy

OBJECTIVES: To evaluate the diagnostic performance of seven non-invasive tests (NITs) of liver fibrosis and to assess fibrosis progression over time in HIV/HCV co-infected patients. METHODS: Transient elastography (TE) and six blood tests were compared to histopathological fibrosis stage (METAVIR)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmid, Patrick, Bregenzer, Andrea, Huber, Milo, Rauch, Andri, Jochum, Wolfram, Müllhaupt, Beat, Vernazza, Pietro, Opravil, Milos, Weber, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587859/ https://www.ncbi.nlm.nih.gov/pubmed/26418061 http://dx.doi.org/10.1371/journal.pone.0138838

Ejemplares similares

Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients
por: Schiavini, Monica, et al.
Publicado: (2011)

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing
por: About, Frédégonde, et al.
Publicado: (2019)

Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection
por: Barone, Michele, et al.
Publicado: (2015)

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?
por: Chin, Jun L., et al.
Publicado: (2016)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy
por: Malekzadeh, Reza, et al.
Publicado: (2011)

Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients
por: Fernández-Alvarez, Paula, et al.
Publicado: (2023)

Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection
por: El-Shabrawi, Mortada Hassan, et al.
Publicado: (2011)

Recurrent Dystrophic Calcification of the Prostatic Resection Cavity After Transurethral Resection of the Prostate: Clinical Presentation and Endoscopic Management
por: Zumstein, Valentin, et al.
Publicado: (2017)

Detection and Significance of Cytotoxic Cell Subsets in Biopsies of HCV-Infected Human Livers
por: Mozer-Lisewska, Iwona, et al.
Publicado: (2013)

Current Strategies for Quantitating Fibrosis in Liver Biopsy
por: Wang, Yan, et al.
Publicado: (2015)

Would the Physicians Eventually Obsolete the Liver Biopsy for the Assessment of Liver Fibrosis?
por: Parsian, Hadi, et al.
Publicado: (2012)

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
por: Nagao, Yumiko, et al.
Publicado: (2014)

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
por: Ortega Gonzalez, Enrique, et al.
Publicado: (2014)

Platelet indices significantly correlate with liver fibrosis in HCV-infected patients
por: Shao, Lin-Nan, et al.
Publicado: (2020)

Liver cancer with concomitant TP53 and CTNNB1 mutations: a case report
por: Friemel, Juliane, et al.
Publicado: (2016)

Liver Transplantation during Pregnancy for Acute Liver Failure due to HBV Infection: A Case Report
por: Kimmich, Nina, et al.
Publicado: (2013)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients
por: Chromy, David, et al.
Publicado: (2017)

Multiple infarcted regenerative nodules in liver cirrhosis after decompensation of cirrhosis: a case series
por: Scholtze, Dieter, et al.
Publicado: (2010)

Analysis of Effect of Antiviral Therapy on Regression of Liver Fibrosis in Patient with HCV Infection
por: Vukobrat-Bijedic, Zora, et al.
Publicado: (2014)

Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection
por: Brescini, Lucia, et al.
Publicado: (2014)

HIV-1 Tropism and Liver Fibrosis in HIV–HCV Co-Infected Patients
por: Abravanel, Florence, et al.
Publicado: (2012)

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017)

Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
por: Nahon, Pierre, et al.
Publicado: (2019)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection
por: Carlisle, Louisa A., et al.
Publicado: (2020)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
por: Kovari, Helen, et al.
Publicado: (2015)

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
por: Gambato, Martina, et al.
Publicado: (2023)

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021)

Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography
por: Wahl, Kristin, et al.
Publicado: (2012)

HCV and Oxidative Stress in the Liver
por: Ivanov, Alexander V., et al.
Publicado: (2013)

Ultrasound shear wave elastography and liver biopsy to determine liver fibrosis in adult patients
por: Gharibvand, Mohammad M., et al.
Publicado: (2020)

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors
por: Latronico, Tiziana, et al.
Publicado: (2016)

Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients
por: Charpentier, Charlotte, et al.
Publicado: (2013)

ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2017)

Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV–HCV-Coinfected Individuals
por: Chen, Xiaochen, et al.
Publicado: (2020)

Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy
por: Procopet, Bogdan, et al.
Publicado: (2017)

Color correction for automatic fibrosis quantification in liver biopsy specimens
por: Murakami, Yuri, et al.
Publicado: (2013)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_51pfa3vcgfv9ir898r8f28u8fi